Ethical Issues for Human Subjects Research: Ethical Issues for Human Subjects Research Role of IRBs
I. Purpose of Human Subjects Research: I. Purpose of Human Subjects Research Understand Disease
Validate New Therapies
Understand Physiological Processes
Study Human Behavior
Evaluate Curricular Changes
Evaluate New Teaching Methods
Ethical Issues in Research: Ethical Issues in Research When using humans or animals for research, important ethical issues must be addressed
Historically, these issues were addressed by the professional code of ethics
Codes of conduct have evolved and now have been codified into law.
Ethical Issues in Research: Ethical Issues in Research World War II—The Nuremburg Trial
Joseph Mengele and unethical experiments performed by Nazi doctors
Ethical Issues in Research: Ethical Issues in Research World War II-The Nuremburg Trial
20 doctors were charged with War Crimes and Crimes against humanity
Joseph Mengele fled and was not tried
Lead to Nuremburg Code of 10 Principles
Nuremburg Code: Nuremburg Code Requires voluntary consent
Experiments must be rational
Experiments must be based on animal studies and knowledge of the disease
Experiments should avoid suffering
No experiment should involve excessive risks, except in those studies where physical experimental physicians also serve as subjects
Nuremburg Code: Nuremburg Code Degree of risks should be determined by importance of the problem
Precautions should be taken to avoid against even remote possibilities of injury, disability, or death
Experiment should be conducted only by scientifically qualified persons
Subjects should be able to end experiment at any time
The scientist in charge must be prepared to terminate the experiment at any stage, if they believe the experiment is likely to result in injury, disability, or death to the subject
Ethical Issues in Research: Ethical Issues in Research Unfortunately, codes were not always followed:
Tuskegee Syphilis Study-USPHS-1930’s
Not treated even after penicillin discovered
Jewish Chronic Disease Hospital
Patients injected with cancer cells
Midgeville State Hospital
Investigational drugs used without consent
Ethical Issues in Research: Ethical Issues in Research Willowbrook State Hospital-1970
Retarded injected with viral hepatitis
US Department of Energy-1950s-60s
Studies on radioactive fallout
University of Iowa-1940s
Research on stuttering in orphans home
Johns Hopkins-2001
Asthma study with hexamethonium
National Research Act: National Research Act Increased Public concern led to congressional action and National Research Act of 1974
President Nixon then established National Commission for the Protection of Human Subjects of Biomedical and Behavioral research
Commission charged to consider:
Boundaries between practice and research
Assessment of role of risk vs. benefit in research
Guidelines for selection of subjects
Informed Consent
Belmont Report: Belmont Report National Commission submitted the Belmont Report to President in 1979
Led to 1981 revision of 1974 guidance (45 CFR 46) for human research committees
45 CFR 46-has become the bible for reviewing research funded by DHHS
Required appointment of Institutional Review Boards or IRB’s to review human subject studies
Provided standards for appointment of IRBs, record-keeping and oversight in research
45 CFR 46: 45 CFR 46 Revised in 1983 and 1991
In 1991 revisions referred to as Common Rule
Adopted by 15 federal agencies, not just DHHS
Institutions with NIH funding must submit assurance of compliance to OHRP, DHHS
After February 28, 2001-assurances must cover all research at institution, not just NIH
II. Institutional Review Boards: II. Institutional Review Boards Makeup of IRB
At least 5 members
Male/Female
Professionals/laypersons
External “non-affiliated” member
Must represent community
Lay person must be at meeting for reviews
II. Institutional Review Boards: II. Institutional Review Boards IRB’S must be guided by principles outlined in Belmont Report:
Respect for persons: respect for patient autonomy
Beneficence: maximize benefits and minimize harm
Justice: Equitable distribution of research burdens and benefits
III. IRB Review of Research: III. IRB Review of Research Three categories of Review:
Exempt
Expedited
Full Review
IRB Review of Research: IRB Review of Research Exempt-by Chair or Administrator
Research in educational settings involving normal educational practices
Instructional strategies
Effectiveness of instructional techniques
Comparison of techniques or curricula, etc.
IRB Review of Research: IRB Review of Research Exempt-by Chair or Administrator
Research involving educational tests (cognitive, diagnostic, aptitude)
Unless
Names or identifiers are recorded and
Disclosure could put subject at risk of criminal liability or affect employability
IRB Review of Research: IRB Review of Research Exempt-by Chair or Administrator
Survey research without identifiers; interviews, observation of public behavior
Unless
Names or identifiers are recorded and
Disclosure could put subject at risk of criminal liability or affect employability
IRB Review of Research: IRB Review of Research Exempt-by Chair or Administrator
Collection or study of existing data, documents, records, pathological or diagnostic specimens
If the sources are publicly available, or
If information is recorded so that the subject cannot be identified, directly or indirectly
IRB Review of Research: IRB Review of Research Exempt-by Chair or Administrator
Research and demonstration projects conducted by or subject to approval by DHHS to study, evaluate or examine:
Public benefit or service programs
Procedures for obtaining benefits or services from these programs
Other changes in these programs
Taste and food quality evaluation and consumer acceptance studies
IRB Review of Research: IRB Review of Research Expedited Review
Research activities reviewed by Chair or designee
Two cautions however:
Only for activities involving minimal risk-i.e., no more risks than those in everyday life
Cannot be used if subject responses might pose civil or criminal risk to subject, unless
Reasonable protections can be implemented so that risks related to invasion of privacy and breach of confidentiality are minimal
IRB Review of Research: IRB Review of Research Expedited Review-Categories eligible
Some studies of approved drugs or devices
Collection of blood from adults
Not to exceed 550mL in 8 weeks
Not more often than 2 times per week
Collection of specimens by non-invasive means: sweat, excreta, amniotic fluid, hair, teeth, plaque
IRB Review of Research: IRB Review of Research Expedited Review-Categories eligible
Collection of data through non-invasive means, excluding X-ray and microwave
EKG, ECG, MRI, weighing, thermography, ultrasound, doppler blood flow, exercise, flexibility testing, etc.
Research involving data, records, specimens collected, or that will be collected solely for non-research purposes
Collection of voice, video, digital, or images made for research purposes
IRB Review of Research: IRB Review of Research Expedited Review-Categories eligible
Research on individual or group characteristics or behavior including:
Perception, cognition, motivation, identity, language, communication, beliefs or practices, etc.
Research involving surveys, interview focus groups, program evaluations, or quality assurance methods
Continuing reviews for previously approved projects
Minor changes in previously approved research
IRB Review of Research: IRB Review of Research Full Review-Full Committee
Investigational drugs, devices, invasive techniques (PET scan), implants, etc.
Higher risk research
NOTE-research not approved by IRB cannot be approved by higher authorities, however approved research may be disapproved by higher authorities
IV. IRB Approval: IV. IRB Approval To be approved:
Risks must be minimized by sound research design
Risks must be reasonable in relation to benefits
Selection of subjects must be equitable
Informed consent will be sought from each subject
IRB Approval: IRB Approval To be approved-continued:
Informed consent will be appropriately documented
When appropriate, research plan must ensure continued safety of subjects
Where appropriate, provisions made to protect privacy of subjects and data
When working with subjects vulnerable to coercion, must consider added safeguards
Continuing Review: Continuing Review For research continuing more than one year, an annual review is required
New standards under review:
Will probably require IRB monitoring of some clinical trials
Constant assessment of conflict of interest of the investigators
Informed Consent: Informed Consent Not needed for exempt studies
Required for Expedited Review-but may be simplified for low risk studies
Rigorous consent for Full Review projects
May be waived by IRB for emergency Medicine research-controversial issue
Informed Consent: Informed Consent Consent must address critical elements or points outlined by Federal Law
Consent signed by subject or legal representative and investigator
Subject must be given copy of consent
No exculpatory language may be used in the written consent
Basic Elements of Consent: Basic Elements of Consent Explanation of purpose and duration
Description of risks
Description of benefits
Disclosure of alternatives to participation
Basic Elements of Consent: Basic Elements of Consent Explanation of Confidentiality of Records
Who to contact regarding patient rights
For research with more than minimal risks, comment on compensation and care for injury
Right to withdraw without prejudice
Statement regarding unforeseen risks, especially to unborn child
Additional Elements for Consent: Additional Elements for Consent Statement that investigator may terminate patient participation
Information regarding any costs
Statement regarding consequences of withdrawing-especially for drug studies
Number of subjects in study
Special Populations-Children: Special Populations-Children Special Considerations
Children are persons who have not attained the legal age for consent to treatments or procedures involved in research
Research not involving greater than minimal risk may be approved:
With assent of the child and permission of parents
Special Populations-Children: Special Populations-Children Special Considerations
Research involving greater than minimal risk and the prospect of direct benefit to the child may be approved:
If the risk is justified by the anticipated benefit
The relation of the benefit to risk is at least as favorable to subjects as the alternative approaches
With assent of the child and permission of parents
Special Populations-Children: Special Populations-Children Special Considerations
Research involving greater than minimal risk and no prospect of direct benefit to the child may be approved:
If the risk represents a minor risk over minimal risk
If the intervention presents experiences that are reasonably similar to those in actual medical, dental, social, psychological, or educational situations
If the intervention is likely to yield generalizeable knowledge about the disorder or condition
With assent of the child and permission of parents
Special Populations-Children: Special Populations-Children Special Considerations
Assent of the child
Usually verbal-confirmed by parents
“Assent” cam usually be provided by children over six years of age-but varies based on maturity and psychological state
Failure to object should not, absent affirmative agreement, be construed as assent
Special Populations-Prisoners: Special Populations-Prisoners Special Considerations
IRB membership
Majority of members must have no association with the prison
Must include a prisoner, or prisoner representative with experience to serve in this capacity
Special Populations-Prisoners: Special Populations-Prisoners Special Considerations
The research may be approved if:
The advantages of participation are not “enticing” or prohibit good judgment
Risks are similar to those for non-prisoner research
Consent is understandable to prison population
Decision to participate will not affect parole
Special Populations-Prisoners: Special Populations-Prisoners Special Considerations
Permitted Research:
Study of causes, effects, or processes involving incarceration
Study of prisons as institutional structures or of prisoners as incarcerated persons
Study of conditions affecting prisoners as a class
Vaccine trials for diseases prevalent in prisons
Study of social behavior of prison population
VI. Federal Oversight: VI. Federal Oversight FDA spot checks IRBs to monitor compliance with drug and device studies
Recent problems at Rush, Duke, UIC, U of Colorado, U of Oklahoma, and Hopkins have prompted calls for greater scrutiny of IRBs
VI. Federal Oversight: VI. Federal Oversight New 2000/2001 DHHS guidelines require:
Training of investigators and “key” personnel in human research protection
Certification by investigators that they have received training (NIH offers on web)
Certification that investigator has no conflict of interest
Monitoring of clinical trials by IRB
VI. Federal Oversight: VI. Federal Oversight Education on “Responsible Conduct of Research”
Nine Areas:
Data acquisition, management, sharing, ownership
Mentor, trainee practices and responsibilities
Publication practices and responsible ownership
Peer review
VI. Federal Oversight: VI. Federal Oversight Education on “Responsible Conduct of Research”
Nine Areas:
Collaborative science
Human subjects
Research involving animals
Research misconduct
Conflict of interest and commitment
VII. New HIPAA regulations: VII. New HIPAA regulations Health Insurance Portability and Accountability Act of 1996
Privacy Rules effective April 14th, 2001
Health insurers must safeguard personal health information
May not disclose to employers for employment-related decisions
However, information can be used for research approved by a properly convened IRB
http://www.hipadvisory.com/regs/finaladvisory/gresearch.htm
HIPAA allows research with conditions: HIPAA allows research with conditions If material has been or can be de-identified, no conflict with HIPAA regulations
Appropriate if records custodian uses data
Often not practical to disclose since records custodian may simply state this is too difficult
HIPAA allows research with conditions: HIPAA allows research with conditions To use or disclose data without patient authorization:
Discloser (records custodian) must document that waiver (of consent) has been obtained from an IRB
or
Researcher must represent in writing or orally, that disclosure is preparatory to research, and no records will be removed or
Researcher must represent in writing or orally that the disclosure is for research on decedents
Document of death may be required by disclosure
Laboratory Research Animals: Laboratory Research Animals
Laboratory Research Animals: Laboratory Research Animals All NIH funded research with animals requires IACUC approval
IACUC or Institutional Animal Care and Use Committee must meet NIH standards
Scientist
Non-scientist
Non-affiliated member
Veterinarian
Laboratory Research Animals: Laboratory Research Animals Functions of the IACUC
Review animal care and use program every six months
Inspect facilities for housing animals every six months
Prepare reports o reviews for Institutional Official
Review concerns involving animals at institution
Make recommendations regarding program to Official
Laboratory Research Animals: Laboratory Research Animals Functions of the IACUC
Review, approve, require modifications in applications for animal use
Review, approve, require modifications of proposed changes in approved animal projects
Suspend activities not adhering to approved uses
Laboratory Research Animals: Laboratory Research Animals To approve animal use:
Procedures must avoid pain or discomfort and have sound research design
Procedures involving minor discomfort or pain must include sedation, analgesia, or anesthesia
Animals that would experience chronic pain must be euthanized at the end of the procedure
Laboratory Research Animals: Laboratory Research Animals To approve animal use:
Living conditions must be appropriate for species
Medical care must be available from veterinarian
Personnel conducting procedures must be qualified
Methods of euthanasia must abide by AVMA rules
Studies approved by IACUC may be disapproved by Institutional offices, however, unapproved studies may not be approved by higher officials
Laboratory Research Animals: Laboratory Research Animals USDA and NIH have oversight
NIH does not have inspection arm
USDA makes periodic, unannounced visits to assess compliance for “covered” species
Case Number 1: Case Number 1 Social scientist
Observing 1st grade play activities
What level of review?
Exempt
Expedited
Full Review
Case Number 2: Case Number 2 Psychologist
Interviewing 1st graders
Benign questions: no names or identifiers
What level of review
Exempt
Expedited
Full Review
Case Number 3: Case Number 3 Behavioral Scientist
Interviewing 3rd graders
Questions regarding sexual behavior, parental handling of bad behavior, etc.
What level of review?
Exempt
Expedited
Full Review
Nuremburg Code: Nuremburg Code The voluntary consent of the human subject is absolutely essential
The experiment should be such as to yield fruitful results for the good of society, unprocurable by other methods or means of study, and not random and unnecessary in nature.
The experiment should be so designed and based on the results of animal experimentation and a knowledge of the natural history of the disease or other problem under study, that the anticipated results will justify the performance of the experiment.
The experiment should be so conducted as to avoid all unnecessary physical and mental suffering and injury.
Nuremburg Code: Nuremburg Code No experiment should be conducted, where there is an a priori reason to believe that death or disabling injury will occur; except, perhaps, in those experiments where the experimental physicians also serve as subjects.
The degree of risk to be taken should never exceed that determined by the humanitarian importance of the problem to be solved by the experiment.
Proper preparations should be made and adequate facilities provided to protect the experimental subject against even remote possibilities of injury, disability, or death.
Nuremburg Code: Nuremburg Code The experiment should be conducted only by scientifically qualified persons. The highest degree of skill and care should be required through all stages of the experiment of those who conduct or engage in the experiment.
During the course of the experiment, the human subject should be at liberty to bring the experiment to an end, if he has reached the physical or mental state, where continuation of the experiment seemed to him to be impossible.
During the course of the experiment, the scientist in charge must be prepared to terminate the experiment at any stage, if he has probable cause to believe, in the exercise of the good faith, superior skill and careful judgment required of him, that a continuation of the experiment is likely to result in injury, disability, or death to the experimental subject.